Publicacións nas que colabora con Juan Jesús Gómez-Reino Carnota (186)

2022

  1. After JAK inhibitor failure: To cycle or to switch, that is the question - Data from the JAK-pot collaboration of registries

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 2, pp. 175-181

  2. Biologics for thyroid eye disease

    Foundational Papers in Oculoplastics (Springer International Publishing), pp. 481-498

2021

  1. Adherence to treatment in patients with rheumatoid arthritis from spain

    Patient Preference and Adherence, Vol. 15, pp. 111-117

2020

  1. Risk/benefit management in the infectious phase in systemic autoimmune rheumatic diseases

    Handbook of Systemic Autoimmune Diseases (Elsevier Ltd), pp. 179-203

2019

  1. Abatacept for the treatment of rheumatoid arthritis

    Expert Review of Clinical Immunology, Vol. 15, Núm. 4, pp. 319-326

  2. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept

    PLoS ONE, Vol. 14, Núm. 2

  3. Objectives and methodology of BIOBADASER phase III

    Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236

  4. Specific Association of HLA–DRB1*03 With Anti–Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 331-339

  5. The role of registries in the treatment of rheumatoid arthritis with biologic disease-modifying anti-rheumatic drugs

    Pharmacological Research, Vol. 148

  6. Visfatin as a therapeutic target for rheumatoid arthritis

    Expert Opinion on Therapeutic Targets, Vol. 23, Núm. 7, pp. 607-618

2018

  1. Correction to: Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology (Rheumatology International, (2018), 38, 3, (467-472), 10.1007/s00296-018-3930-7)

    Rheumatology International

  2. Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial

    American Journal of Ophthalmology, Vol. 195, pp. 181-190

  3. Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: Results from BIOBADASER

    Arthritis Research and Therapy, Vol. 20, Núm. 1

  4. Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis

    Scientific Reports, Vol. 8, Núm. 1

  5. Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis

    PLoS ONE, Vol. 13, Núm. 5

2017

  1. Adipokines induce pro-inflammatory factors in activated Cd4+ T cells from osteoarthritis patient

    Journal of Orthopaedic Research, Vol. 35, Núm. 6, pp. 1299-1303

  2. Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients

    PLoS ONE, Vol. 12, Núm. 7

  3. Leptin in the interplay of inflammation, metabolism and immune system disorders

    Nature Reviews Rheumatology, Vol. 13, Núm. 2, pp. 100-109

2016

  1. Anti-carbamylated protein antibodies as a reproducible independent type of rheumatoid arthritis autoantibodies

    PLoS ONE, Vol. 11, Núm. 8

  2. Independent candidate serum protein biomarkers of response to adalimumab and to infliximab in rheumatoid arthritis: An exploratory study

    PLoS ONE, Vol. 11, Núm. 4